About_editors 1..1 - Free

Aminoglycosides 175168. Parker SE, Davey PG. Once-daily aminoglycoside administration in gram-negativesepsis: economic and practical aspects. Pharmacoeconomics 1995; 7:393–402.169. Klepser ME. Role of nebulized antibiotics for the treatment of respiratory infections.Curr Opin Infect Dis 2004; 17(2):109–112.170. Flume P, Klepser ME. The rationale for aerosolized antibiotics. Pharmacotherapy2002; 22(3 Pt 2):71S–79S.171. Tiddens H. Inhaled antibiotics. Pediatr Pulmonol Suppl 2004; 26:92–94.172. Cole PJ. The role of nebulized antibiotics in treating serious respiratory infections. JChemother 2001; 13(4):354–362.173. de Boer AH, Hagedoorn P, Frijlink HW. The choice of a compressor for the aerosolisationof tobramycin (TOBI) with the PARI LC PLUS reusable nebuliser. Int J Pharm2003; 268(1–2):59–69.174. Cheer SM, Waugh J, Noble S. Inhaled tobramycin (TOBI): a review of its use in themanagement of Pseudomonas aeruginosa infections in patients with cystic fibrosis.Drugs 2003; 63(22):2501–2520.175. Eisenberg J, Pepe M, Williams-Warren J, et al. A comparison of peak sputumtobramycin concentration in patients with cystic fibrosis using jet and ultrasonicnebulizer systems. Aerosolized Tobramycin Study Group. Chest 1997; 111(4):955–962.176. Geller DE, Pitlick WH, Nardella PA, Tracewell WG, Ramsey BW. Pharmacokineticsand bioavailability of aerosolized tobramycin in cystic fibrosis. Chest 2002; 122(1):219–226.177. Moss RB. Administration of aerosolized antibiotics in cystic fibrosis patients. Chest2001; 120(3 suppl):107S–113S.178. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaledtobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin StudyGroup. N Engl J Med 1999; 340(1):23–30.179. Barker AF, Couch L, Fiel SB, et al. Tobramycin solution for inhalation reduces sputumPseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 2000;162(2 Pt 1):481–485.180. Newhouse MT, Hirst PH, Duddu SP, et al. Inhalation of a dry powder tobramycinPulmoSphere formulation in healthy volunteers. Chest 2003; 124(1):360–366.181. Al-Kassas R. Design and in vitro evaluation of gentamicin-Eudragit microspheresintended for intra-ocular administration. J Microencapsul 2004; 21(1):71–81.182. Sterling GJ, Crawford S, Potter JH, Koerbin G, Crawford R. The pharmacokinetics ofsimplex-tobramycin bone cement. J Bone Joint Surg Br 2003; 85(5):646–649.183. Fletcher MD, Spencer RF, Langkamer VG, Lovering AM. Gentamicin concentrationsin diagnostic aspirates from 25 patients with hip and knee arthroplasties. Acta OrthopScand 2004; 75(2):173–176.184. Nishimoto K, Yamamura K, Fukase F, Kobayashi M, Nishikimi N, Komori K.Subcutaneous tissue release of amikacin from a fibrin glue/polyurethane graft. J InfectChemother 2004; 10(2):101–104.